|
ME2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.859700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.264200E-02 |
| Normal-vs-Stage2 |
3.394400E-02 |
| Normal-vs-Stage3 |
8.352800E-04 |
| Normal-vs-Stage4 |
1.240330E-02 |
| Stage1-vs-Stage2 |
4.285200E-01 |
| Stage1-vs-Stage3 |
4.566200E-02 |
| Stage1-vs-Stage4 |
3.528600E-01 |
| Stage2-vs-Stage3 |
5.722800E-01 |
| Stage2-vs-Stage4 |
9.477800E-01 |
| Stage3-vs-Stage4 |
5.976600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.999200E-03 |
| Normal-vs-AfricanAmerican |
9.173600E-02 |
| Normal-vs-Asian |
2.973700E-02 |
| Caucasian-vs-AfricanAmerican |
7.848800E-01 |
| Caucasian-vs-Asian |
7.495400E-01 |
| AfricanAmerican-vs-Asian |
9.742000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.942300E-03 |
| Normal-vs-Female |
1.027520E-02 |
| Male-vs-Female |
6.765400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.826400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.029900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.821570E-02 |
| Normal-vs-Age(81-100Yrs) |
2.877400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.145610E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.555800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.629600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.185200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.028400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.554400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.686400E-01 |
| Classical-VS-Follicular |
8.625000E-01 |
| Classical-VS-Other |
3.974000E-01 |
| Classical-VS-Normal |
9.940500E-03 |
| Tall-VS-Follicular |
8.948800E-01 |
| Tall-VS-Other |
3.951600E-01 |
| Tall-VS-Normal |
6.682000E-02 |
| Follicular-VS-Other |
5.330800E-01 |
| Follicular-VS-Normal |
2.288000E-02 |
| Other-VS-Normal |
3.692500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.340100E-03 |
| Normal-vs-N1 |
1.298050E-03 |
| N0-vs-N1 |
4.752000E-01 |
|
|
